Dominique Thabut

发表

MetaboRank: network-based recommendation system to interpret and enrich metabolomics results

Fabien Jourdan, Benoit Colsch, Florence Vinson, 2018, Bioinform..

Meta-analyses of FibroTest diagnostic value in chronic liver disease

Patrice Cacoub, Fabien Zoulim, Dominique Thabut, 2007, BMC gastroenterology.

Slow regression of liver fibrosis presumed by repeated biomarkers after virological cure in patients with chronic hepatitis C.

Christine Katlama, Dominique Thabut, Y. Ngo, 2013, Journal of hepatology.

The diagnostic value of biomarkers (SteatoTest) for the prediction of liver steatosis

Dominique Thabut, Y. Ngo, D. Thabut, 2005, Comparative hepatology.

Incidence of Hepatocellular Carcinoma After Direct Antiviral Therapy for HCV in Patients With Cirrhosis Included in Surveillance Programs.

Albert Tran, Vincent Leroy, Dominique Larrey, 2018, Gastroenterology.

Liver fibrosis evaluation using real-time shear wave elastography: applicability and diagnostic performance using methods without a gold standard.

Dominique Thabut, Y. Ngo, M. Rudler, 2013, Journal of hepatology.

Diagnostic performance of FibroTest, SteatoTest and ActiTest in patients with NAFLD using the SAF score as histological reference

Chris Day, Fritz Wrba, Debbie Lawlor, 2016, Alimentary pharmacology & therapeutics.

Daclatasvir plus simeprevir with or without ribavirin for the treatment of chronic hepatitis C virus genotype 1 infection.

Ronald Pruitt, Stefan Zeuzem, Dominique Thabut, 2016, Journal of hepatology.

Diagnostic value of biochemical markers (NashTest) for the prediction of non alcoholo steato hepatitis in patients with non-alcoholic fatty liver disease

Dominique Thabut, Mohamed Tahiri, V. de Lédinghen, 2006, BMC gastroenterology.

Ranking hepatologists: which Hirsch's h-index to prevent the "e-crise de foi-e"?

Dominique Thabut, D. Thabut, T. Poynard, 2011, Clinics and research in hepatology and gastroenterology.